Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
27.12
-0.42 (-1.53%)
At close: Apr 28, 2026, 4:00 PM EDT
27.12
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Koninklijke Philips Revenue
In the year 2025, Koninklijke Philips had annual revenue of 17.83B EUR, down -1.04%. Koninklijke Philips had revenue of 5.10B in the quarter ending December 31, 2025, with 1.07% growth.
Revenue (ttm)
17.83B EUR
Revenue Growth
-1.04%
P/S Ratio
1.23
Revenue / Employee
272,942 EUR
Employees
65,340
Market Cap
25.79B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.83B | -187.00M | -1.04% |
| Dec 31, 2024 | 18.02B | -148.00M | -0.81% |
| Dec 31, 2023 | 18.17B | 342.00M | 1.92% |
| Dec 31, 2022 | 17.83B | 671.00M | 3.91% |
| Dec 31, 2021 | 17.16B | -157.00M | -0.91% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.23B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
PHG News
- 5 days ago - PHG Makes Notable Cross Below Critical Moving Average - Nasdaq
- 5 days ago - Royal Philips: Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - Finanz Nachrichten
- 5 days ago - Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - GlobeNewsWire
- 6 days ago - Philips (PHG) Secures FDA Clearance for Rembra Scanning Systems - GuruFocus
- 6 days ago - Royal Philips: Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finanz Nachrichten
- 6 days ago - Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - GlobeNewsWire
- 11 days ago - Koninklijke Philips NV (PHG) Shares Surge 3.7% -- What GF Score of 79 Tells Investors - GuruFocus
- 11 days ago - Weekly Buzz: FDA Okays TVTX, PHG; Rejects REPL; AIP Snaps Up AVNS; PDS, HOTH, SYRE, Paces Trials - Finanz Nachrichten